Culture Biosciences GTM brain

Culture Biosciences provides cloud-connected bioreactors, software and development services to biotech and biopharma teams running cell culture experiments.

category

Bioprocess development platforms

market profile

  • text: Culture combines outsourced bioprocess development with cloud-connected hardware and software for in-lab experimentation.
  • text: Its stated applications span synthetic biology, protein therapeutics and viral vectors.

personas

  • title: Director of bioprocess development
    pains:
    • Limited bioreactor capacity slows process characterization and development.
    • Needs reproducible data to make process decisions sooner and reduce development delays.
  • title: Fermentation or cell culture scientist
    pains:
    • Experiments require frequent monitoring and data are scattered across instruments.
    • Collaborators need real-time access to experimental conditions and results.
  • title: Biotech R&D executive
    pains:
    • Must accelerate development without building all experimental capacity internally.
    • Needs confidence that process work will support eventual scale-up and commercialization.

icp

  • text: Biotech and biopharma organizations developing protein therapeutics or viral vectors using cell culture.
  • text: Synthetic biology companies scaling microbial processes for food, materials or other bio-based products; no firm size minimum is stated.

message pillars

  • text: Remove bottlenecks in bioprocess development.
  • text: Let teams run and analyze experiments remotely.
  • text: Make experiment data immediately accessible for distributed collaboration.
  • text: Use analytics and monitoring to inform process decisions.

objections

  • objection: Will external experiments give us sufficient visibility and control?
    response: Culture describes real-time monitoring and remote access through Console; assess data access and operating procedures in a pilot.
  • objection: Will results translate to our process and scale?
    response: Discuss organism or cell line, operating conditions and scale-up criteria with the team before committing a full program.
  • objection: Should we buy internal equipment instead of outsourcing?
    response: Compare the Stratyx in-lab platform and outsourced service against available staffing, capacity and timelines.

competitors

  • name: Boston Bioprocess
    why: Bioprocess scale-up and development provider listed by CB Insights as a competitor.
  • name: Thermo Fisher Scientific
    why: Offers bioreactors and bioprocess equipment that can support internal development workflows.

influencers

  • name: Will Patrick
    url: https://www.media.mit.edu/articles/culture-s-founding-story-an-interview-with-ceo-will-patrick/
    why: Co-founder interviewed about the company's founding and bioprocess work.

keywords

  • cloud bioreactor
  • bioprocess development services
  • cell culture process development
  • fermentation scale up
  • bioreactor experiment monitoring
  • high throughput bioprocess development

voice

  • Scientific and practical
  • Efficiency and collaboration oriented

signals

  • text: A biotech team is moving an engineered organism or cell line toward manufacturing process development.
  • text: A lab is adding cell culture experiments but lacks bioreactor capacity or remote data visibility.
  • text: A company is developing a new viral vector or protein therapeutic and needs process characterization.

stack

  • Culture Console
  • Cloud-connected bioreactors

pricing

model: unknown

motion

sales_led

channels

  • Website
  • Technical content
  • Webinars
  • LinkedIn
  • Sales demos

confidence

high

Founders

  • name: Will Patrick
    title: Founder/CEO
    role: CEO
    bio: A founder, engineer, and researcher interested in biology, robotics, fabrication, music, and more. I co-founded Culture Biosciences, where I served as CEO for 8 years, building cloud-based bioprocessing technology.
  • name: Matt Ball
    title: Founder/CTO
    role: CTO
    bio: https://oakmachine.com

Back to YC companies